Yes, Puma Biotechnology, Inc. is a publicly traded biopharmaceutical enterprise listed on the NASDAQ Global Select Market under the ticker symbol PBYI. Institutional asset managers, mutual funds, and public retail investors can freely buy and sell its common stock, which is subject to standard regulatory reporting requirements and biotech sector market volatility.